The Application of Fungal Beta-glucans for the Treatment of Colon Cancer
- 作者: Chen J.1, Zhang X.D.1, Jiang Z.1
-
隶属关系:
- ,
- 期: 卷 13, 编号 5 (2013)
- 页面: 725-730
- 栏目: Oncology
- URL: https://genescells.com/1871-5206/article/view/694930
- DOI: https://doi.org/10.2174/1871520611313050007
- ID: 694930
如何引用文章
全文:
详细
Mushrooms have been consumed for their health benefits for thousands of years in China, and the main active component was recently identified as beta-glucan. The immune-stimulating effect of beta-glucans has been well studied, and several beta-glucan receptors have been identified on the surface of immune cells. In addition, mushroom extracts with high levels of beta-glucans have also been shown to have direct cytotoxic effects on cancer cells, and beta-glucans are used for the treatment of cancer. This review summarizes the use of beta-glucans in colon cancer. Evidence has supported the idea that beta-glucans can decrease the size of xenografted colon cancer tumors via the stimulation of the immune system and direct cytotoxicity. Beta-glucans can also have synergistic effects with chemotherapeutic agents and other immune stimulators, and an innovative strategy is to use beta-glucans to deliver nanoparticles containing chemotherapeutic agents to the site of the colon cancer and, thus, improve the therapeutic efficacy.
作者简介
Jiezhong Chen
,
Email: info@benthamscience.net
Xu Zhang
,
Email: info@benthamscience.net
Zhengyi Jiang
,
Email: info@benthamscience.net
补充文件
